Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 67(3): 2049-2065, 2024 Feb 08.
Article in English | MEDLINE | ID: mdl-38284310

ABSTRACT

Human genetic evidence shows that PDE3B is associated with metabolic and dyslipidemia phenotypes. A number of PDE3 family selective inhibitors have been approved by the FDA for various indications; however, given the undesirable proarrhythmic effects in the heart, selectivity for PDE3B inhibition over closely related family members (such as PDE3A; 48% identity) is a critical consideration for development of PDE3B therapeutics. Selectivity for PDE3B over PDE3A may be achieved in a variety of ways, including properties intrinsic to the compound or tissue-selective targeting. The high (>95%) active site homology between PDE3A and B represents a massive obstacle for obtaining selectivity at the active site; however, utilization of libraries with high molecular diversity in high throughput screens may uncover selective chemical matter. Herein, we employed a DNA-encoded library screen to identify PDE3B-selective inhibitors and identified potent and selective boronic acid compounds bound at the active site.


Subject(s)
DNA , Heart , Humans , Catalytic Domain , Cyclic Nucleotide Phosphodiesterases, Type 3
2.
ACS Med Chem Lett ; 3(7): 524-9, 2012 Jul 12.
Article in English | MEDLINE | ID: mdl-24900504

ABSTRACT

A novel thiazolopyrimidinone series of PI3K-beta selective inhibitors has been identified. This chemotype has provided an excellent tool compound, 18, that showed potent growth inhibition in the PTEN-deficient breast cancer cell line MDA-MB-468 under anchorage-independent conditions, and it also demonstrated pharmacodynamic effects and efficacy in a PTEN-deficient prostate cancer PC-3 xenograft mouse model.

3.
J Hered ; 98(5): 534-8, 2007.
Article in English | MEDLINE | ID: mdl-17573382

ABSTRACT

Primary lens luxation (PLL), a painful and blinding inherited condition, is common in several breeds of terrier. Here we have examined the Veterinary Medical Database of patient encounters and Canine Eye Registration Foundation (CERF) cases records for the last 10 years and found the diagnosis recorded in 85 breeds. We have performed association analysis using a genome-wide microsatellite screen to map mutations underlying the condition in miniature bull terriers and Lancashire heelers. These studies show microsatellite alleles in disequilibrium with disease status with highest support in a 6.3-Mbp region in the central part of chromosome 3 (-log P(max) = 6.4). The same region also shows an association to the disease in Tibetan terriers. Tight junction protein-1 (TJP1) is a positional candidate to contain the PLL mutation. All recognized exons and splice junctions of TJP1 have been sequenced from affected, obligate carrier and control Lancashire heeler dogs. Several polymorphisms have been found, but these are not likely to cause the disease.


Subject(s)
Dogs/genetics , Lens Subluxation/genetics , Lens, Crystalline , Mutation , Animals , Chromosome Mapping , Genetic Markers , Genetic Predisposition to Disease , Membrane Proteins/genetics , Phosphoproteins/genetics , Species Specificity
4.
J Biol Chem ; 279(41): 42476-83, 2004 Oct 08.
Article in English | MEDLINE | ID: mdl-15280391

ABSTRACT

The anthelmintic drug levamisole causes hypercontraction of body wall muscles and lethality in nematode worms. In the nematode Caenorhabditis elegans, a genetic screen for levamisole resistance has identified 12 genes, three of which (unc-38, unc-29, and lev-1) encode nicotinic acetylcholine receptor (nAChR) subunits. Here we describe the molecular and functional characterization of another levamisole-resistant gene, unc-63, encoding a nAChR alpha subunit with a predicted amino acid sequence most similar to that of UNC-38. Like UNC-38 and UNC-29, UNC-63 is expressed in body wall muscles. In addition, UNC-63 is expressed in vulval muscles and neurons. We also show that LEV-1 is expressed in body wall muscle, thus overlapping the cellular localization of UNC-63, UNC-38, and UNC-29 and suggesting possible association in vivo. This is supported by electrophysiological studies on body wall muscle, which demonstrate that a levamisole-sensitive nAChR present at the C. elegans neuromuscular junction requires both UNC-63 and LEV-1 subunits. Thus, at least four subunits, two alpha types (UNC-38 and UNC-63) and two non-alpha types (UNC-29 and LEV-1), can contribute to levamisole-sensitive muscle nAChRs in nematodes.


Subject(s)
Caenorhabditis elegans Proteins/chemistry , Caenorhabditis elegans Proteins/physiology , Levamisole/pharmacology , Receptors, Nicotinic/chemistry , Receptors, Nicotinic/physiology , Alleles , Amino Acid Sequence , Animals , Antinematodal Agents/pharmacology , Caenorhabditis elegans , Cloning, Molecular , DNA, Complementary/metabolism , Electrophysiology , Models, Genetic , Molecular Sequence Data , Muscles/metabolism , Mutation , Neurons/metabolism , Nucleic Acid Hybridization , Peptides/chemistry , Phylogeny , Protein Structure, Tertiary , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Transgenes
SELECTION OF CITATIONS
SEARCH DETAIL
...